Minerva Neurosciences regains Nasdaq compliance with net income rule

Minerva Neurosciences, Inc.

Nasdaq Panel confirmed compliance with Listing Rule 5550(b)(3) (minimum $500K net income from continuing operations).
Company subject to a one-year discretionary monitor; any future deficiency triggers automatic delist process.
Prior deficiencies for Market Value of Listed Securities (<$35M) and Equity Rule are now resolved.
Panel closed the matter; listing on Nasdaq Capital Market continues effective March 17, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.